Search clinical trials for: HS-10390 tablet

Total 7577 results

Eli Lilly and Company

Completed

A Study of Baricitinib in Healthy Participants

Healthy

Singapore
University Hospital, Grenoble

Unknown

Severe Chronic Respiratory Failure and Citrulline

Pulmonary Disease, Chronic Obstructive

France
Mission Pharmacal

Unknown

Phase II Proof of Concept Study in Uncomplicated UTI

Urinary Tract Infections

United States
ALK-Abelló A/S
Inflamax Research Incorporated

Completed

A Dose-response Evaluation of the SQ Tree SLIT-tablet Using an Environmental Exposure Chamber

Allergic Rhinoconjunctivitis

Canada
University Hospital, Geneva

Unknown

Tablet-guided Versus Freehand (Tab-Guide) Ventriculostomy : Study Protocol to the Test Accuracy of Ventriculostomy in a Randomized Controlled Trial (Tab-Guide)

Hydrocephalus.

Switzerland
Pfizer
Medivation, Inc.

Terminated

An Extension To The B1451006 Protocol To Evaluate The Safety and Efficacy of Dimebon In Subjects With Moderate-to-Severe Alzheimer's Disease

Alzheimer's Disease

United States
Jiangsu vcare pharmaceutical technology co., LTD

Recruiting

Efficacy and Safety Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis

Moderate to Severe Atopic Dermatitis

China
Shenzhen NewDEL Biotech, Co., Ltd
Shenzhen Innovation Center for Small Molecule Drug Discovery Co., Ltd.

Enrolling by invitation

An Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of ND-003 in Patients With Advanced Solid Cancers

Advanced Solid Tumor

China
Akros Pharma Inc.

Completed

Study to Evaluate the Efficacy and Safety of JTE-451 in Subjects With Moderate to Severe Plaque Psoriasis (IMPACT-PS)

Skin Diseases | Psoriasis | Plaque Psoriasis

United States, Canada, Poland
Seed Health

Active, not recruiting

Randomized, Double-Blind Placebo-Controlled Trial to Assess Overall User Experience of a Synbiotic Vaginal Suppository

Vaginal Personal Care

United States
Boryung Pharmaceutical Co., Ltd

Withdrawn

A Study to Compare the Pharmacokinetics and Safety/Tolerability of BR-UPS (Ulipristal Acetate) 5 mg Tablet With Inisia (Ulipristal Acetate) 5 mg Tablet

Uterine Myoma

Korea, Republic of
Guang'anmen Hospital of China Academy of Chinese...

Unknown

Efficacy and Safety of Xueshuanxinmaining Tablet for the Treatment of Stable Angina Pectoris

Coronary Heart Disease | Stable Angina
McNeil AB

Completed

A Comparison of Three Medications to Treat Diarrhea in Adults.

Diarrhea

India, Mexico
University of Tartu

Completed

The Effect of Semaglutide on Pituitary Function

Healthy

Estonia
ShuGuang Hospital
Hubei Hospital of Traditional Chinese Medicine; Wuhan No.1 Hospital; Wuhan Third... and other collaborators

Completed

Treatment of Pulmonary Fibrosis Due to COVID-19 With Fuzheng Huayu

Pulmonary Fibrosis Due to COVID-19

China
AstraZeneca

Completed

A Study to Assess the Bioequivalence of R406 in Healthy Volunteers When Given 100mg and 150 mg of Fostamatinib (Fosta BE)

Healthy Volunteers

United States
GlaxoSmithKline

Completed

A Single Dose Study to Assess the Regional Absorption and Bioavailability of 100mg GSK2190915A

Asthma

United Kingdom
Boehringer Ingelheim

Completed

Bioavailability of a Fixed Dose Combination Tablet With Empagliflozin (BI 10773) and Metformin Compared With the Monocomponents and Effect of Food on Bioavailability

Diabetes Mellitus, Type 2

Germany
Luye Pharma Group Ltd.

Not yet recruiting

Effect of Food on the Pharmacokinetics of LPM3770164 Sustained-release Tablets

Tardive Dyskinesia | Huntington Disease

China
BDH-Klinik Hessisch Oldendorf
Gottfried Wilhelm Leibniz Universität Hannover

Recruiting

Sensorimotor Arm Rehabilitation After Stroke (TAB-APP)

Stroke | Hemiparesis

Germany
Shanghai YingLi Pharmaceutical Co. Ltd.

Not yet recruiting

A Study of Linperlisib Combination With Camrelizumab in Patients With Solid Tumor

Advanced Solid Tumor
Indiana University
National Institute on Alcohol Abuse and Alcoholism (NIAAA); Cedars-Sinai Medical...

Recruiting

SAMe Trial for Patients With Alcoholic Cirrhosis

Alcoholic Cirrhosis

United States
University of Vermont
Duke University

Completed

MitoQ for the Treatment of Metabolic Dysfunction in Asthma (MIMDA)

Obesity | Asthma

United States
Simcere Pharmaceutical Co., Ltd

Completed

A Study to Evaluate the Pharmacokinetics,Safety and Tolerability of Y-2 Sublingual Tablet in Healthy Adult Subjects

Healthy

United States
Guangzhou Lupeng Pharmaceutical Company LTD.

Completed

A Food Effect Study of LP-168 Tablets in Healthy Subjects

Mantle Cell Lymphoma

China
Pipeline Therapeutics, Inc.

Completed

Phase I Study Evaluating Safety and Tolerability of Escalating Single and Multiple Doses of of PIPE-307 and Food Effect in Healthy Volunteers

Multiple Sclerosis

Australia
Cerevel Therapeutics, LLC

Completed

An Open-label Trial to Evaluate Mass Balance of Tavapadon at Steady State in Healthy Subjects

Healthy Subjects

United States
Calo Psychiatric Center

Completed

Therapeutic Effect of Cassia Seed in Obesity of Patients With Schizophrenia

Schizophrenia

Taiwan
Rhode Island Hospital
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

An Emotion Regulation Intervention for Early Adolescent Risk Prevention

Risk Behavior | Risk Reduction | Emotion Regulation

United States
Qilu Pharmaceutical Co., Ltd.

Unknown

A Study to Investigate the Safety, Efficacy and Pharmacokinetic Profile of Multiple Doses of QL-007 in Chronic Hepatitis B Patients

Chronic Hepatitis b

New Zealand
Convalife (Shanghai) Co., Ltd.

Not yet recruiting

CVL237 Tablets for APDS/PASLI

PI3K and P110delta Hyperactivation Syndrome

China
Chengdu Suncadia Medicine Co., Ltd.

Active, not recruiting

A Phase II Clinical Study of the Efficacy and Safety of HRS9950 Tablets in Chronic Hepatitis B Patients Who Are Virologically Suppressed on Nucleoside or Nucleotide Analogues (NAs)

Chronic Hepatitis B

China
Jiangsu vcare pharmaceutical technology co., LTD

Completed

A Phase I Clinical Study of VC005 Tablets in Subjects With Rheumatoid Arthritis.

Rheumatoid Arthritis

China
Reckitt Benckiser Healthcare (UK) Limited
Premier Research Group plc

Completed

Efficacy of 300 mg Ibuprofen Prolonged-Release Tablets for the Treatment of Pain After Surgical Removal of Impacted Third Molars

Pain

United States
Pfizer

Recruiting

A Study for Multiple Tablet Forms of The Study Medicine (PF-07220060) in Healthy Adults

Healthy Participants

United States
Bayer

Completed

Study on the Safety of the Drug BAY2395840 at Different Doses, the Way the Body Absorbs, Distributes and Excretes the Drug Including the Effect of Its Formulation (Tablet or Liquid) and the Effect of Food on the Absorption, Distribution or Excretion of the Drug in Healthy Male Participants

Endometriosis

Germany
GlaxoSmithKline

Completed

A Fixed Dose Study of 323U66 SR in the Treatment of Major Depressive Disorder (MDD)

Depressive Disorder, Major

Korea, Republic of, Japan
Abbott
Ascent; Datamap; ClinIntel; Catalent

Completed

Study With Heptral in Subjects With Liver Disease Due to Alcohol Consumption

Intrahepatic Cholestasis Associated With Alcoholic Liver Disease

Russian Federation
Gedeon Richter Plc.

Completed

Cariprazine: Comparison of Slow- and Immediate-release Forms

Pharmacokinetic Profile

United Kingdom
LegoChem Biosciences, Inc

Completed

To Evaluate the Effect of Food on Pharmacokinetics(PK), Phase I Clinical Study of LCB01-0371

Healthy

Korea, Republic of
SIGA Technologies
PPD; Biomedical Advanced Research and Development Authority

Completed

Drug-drug Interaction Study of TPOXX When Co-administered With Phosphate Binders

Smallpox

United States
Jiangsu HengRui Medicine Co., Ltd.

Active, not recruiting

Relative Bioavailability Study of SHR3680 (SHR-3680)

Healthy Male Subjects

China
GlaxoSmithKline

Completed

GSK189075, GW869682 Or Placebo In Type 2 Diabetic Patients

Diabetes Mellitus, Type 2 | Non-Insulin-Dependent Diabetes Mellitus

Germany, United States
University of California, Davis

Recruiting

Senicapoc in Alzheimer's Disease (Senicapoc)

Alzheimer Disease | Mild Cognitive Impairment

United States
West German Study Group
Novartis; Genomic Health®, Inc.

Recruiting

Adj. Marker-adjusted Personalized Therapy Comparing ET+Ribociclib vs Chemotherapy in Intermediate Risk, HR+/HER2- EBC (ADAPTcycle)

Breast Cancer Female

Germany
Sinew Pharma Inc.

Not yet recruiting

A Randomized, Double-Blind, Placebo Controlled Study to Assess the Efficacy and Safety of SNP-610 for the Treatment of Patients With Non-alcoholic Steatohepatitis

NASH - Nonalcoholic Steatohepatitis
UNICANCER

Recruiting

A Phase II Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone Sarcomas (REGOBONE)

Chondrosarcomas | Ewing Sarcomas | Osteosarcomas | Chondroma | CIC-Rearranged Sarcoma

France
MapLight Therapeutics

Enrolling by invitation

ML-004 Open-Label Extension Study in Adults and Adolescents With Autism Spectrum Disorders (ASD)

Autism Spectrum Disorder

United States, Canada, Australia
Chong Kun Dang Pharmaceutical

Completed

Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic After Oral Administration of CKD-341 and D956 in Healthy Adults

Hypertension

Korea, Republic of
Alto Neuroscience

Completed

ALTO-300 in Depression

Major Depressive Disorder

United States

3

Subscribe